CG Oncology, Inc. Common stock (CGON) — Working Capital to Net Assets Ratio
CG Oncology, Inc. Common stock (CGON) has a Working Capital to Net Assets ratio of 96.8% as of December 2025. Working capital of $728.64 Million (current assets of $759.48 Million minus current liabilities of $30.84 Million) is measured against net assets of $752.60 Million. A higher ratio indicates strong short-term liquidity financed by the equity base. See CG Oncology, Inc. Common stock balance sheet independence to measure how much of total assets are equity-financed.
WC/NA Ratio
Working Capital
Current Assets
Current Liabilities
CG Oncology, Inc. Common stock Working Capital to Net Assets (2021–2025)
This chart shows how CG Oncology, Inc. Common stock's Working Capital to Net Assets ratio has evolved across 5 annual periods from 2021 to 2025. As of December 2025, the ratio stands at 96.8%, reflecting working capital of $728.64 Million against net assets of $752.60 Million USD. Check CGON tangible net assets ratio to evaluate the tangible quality of the company's equity base.
Annual Working Capital to Net Assets for CG Oncology, Inc. Common stock (2021–2025)
The table below presents the year-by-year Working Capital to Net Assets ratio for CG Oncology, Inc. Common stock from 2021 to 2025, covering 5 annual filings. Each row shows current assets, current liabilities, working capital, net assets, the ratio, and the change in percentage points compared to the prior year. For live market cap and the full company profile, see market cap of CG Oncology, Inc. Common stock.
| Year | WC/NA Ratio | Working Capital (USD) | Net Assets | Current Assets | Current Liabilities | Change (pp) |
|---|---|---|---|---|---|---|
| 2025 | 96.8% | $728.64 Million | $752.60 Million | $759.48 Million | $30.84 Million | ▼ -3.1 pp |
| 2024 | 99.9% | $732.84 Million | $733.38 Million | $754.21 Million | $21.37 Million | ▲ +2.6 pp |
| 2023 | 97.3% | $179.87 Million | $184.79 Million | $194.12 Million | $14.25 Million | ▼ -7.9 pp |
| 2022 | 105.3% | $131.78 Million | $125.18 Million | $147.21 Million | $15.43 Million | ▼ -25.0 pp |
| 2021 | 130.3% | $52.43 Million | $40.25 Million | $58.41 Million | $5.97 Million | — |